These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30563358)

  • 81. METABOLIC SYNDROME - THEORY AND PRACTICE.
    Ramic E; Prasko S; Mujanovic OB; Gavran L
    Mater Sociomed; 2016 Feb; 28(1):71-3. PubMed ID: 27047273
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention.
    Fried TR; Tinetti ME; Towle V; O'Leary JR; Iannone L
    Arch Intern Med; 2011 May; 171(10):923-8. PubMed ID: 21357797
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Coronary artery calcium and primary prevention risk assessment: what is the evidence? An updated meta-analysis on patient and physician behavior.
    Whelton SP; Nasir K; Blaha MJ; Gransar H; Metkus TS; Coresh J; Berman DS; Blumenthal RS
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):601-7. PubMed ID: 22811506
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Quantifying the health benefits of chronic disease prevention: a fresh approach using cardiovascular disease as an example.
    Wald NJ; Morris JK
    Eur J Epidemiol; 2014 Sep; 29(9):605-12. PubMed ID: 25063437
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Awareness and adherence to primary and primordial preventive measures among family members of patients with myocardial infarction-the unmet need for a "Preventive Clinic".
    Dahiya N; Sharma V; Kumar B; Thakur JS; Kumar S
    Indian Heart J; 2020; 72(5):454-458. PubMed ID: 33189213
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Secondary prevention of myocardial infarction with nonpharmacologic strategies in a Medicaid cohort.
    Oberg EB; Fitzpatrick AL; Lafferty WE; LoGerfo JP
    Prev Chronic Dis; 2009 Apr; 6(2):A52. PubMed ID: 19288995
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Aspirin Use among Adults with Cardiovascular Disease in the United States: Implications for an Intervention Approach.
    Ansa BE; Hoffman Z; Lewis N; Savoy C; Hickson A; Stone R; Johnson T
    J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30791560
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prevention of stroke: a strategic global imperative.
    Feigin VL; Norrving B; George MG; Foltz JL; Roth GA; Mensah GA
    Nat Rev Neurol; 2016 Sep; 12(9):501-12. PubMed ID: 27448185
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Recommendations of the Spanish Society of Neurology for the prevention of stroke. Interventions on lifestyle and air pollution.
    García Pastor A; López-Cancio Martínez E; Rodríguez-Yáñez M; Alonso de Leciñana M; Amaro S; Arenillas JF; Ayo-Martín O; Castellanos M; Fuentes B; Freijo MM; Gomis M; Gómez Choco M; Martínez Sánchez P; Morales A; Palacio-Portilla EJ; Segura T; Serena J; Vivancos-Mora J; Roquer J;
    Neurologia (Engl Ed); 2021 Jun; 36(5):377-387. PubMed ID: 34714236
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Primary prevention of cardiovascular disease in older adults in China.
    Yong J; Lin D; Tan XR
    World J Clin Cases; 2017 Sep; 5(9):349-359. PubMed ID: 29026833
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Primary Prevention of Acute Stroke].
    Scutelnic A; Streit S; Sarikaya H; Jung S; Heldner MR
    Praxis (Bern 1994); 2020; 109(4):277-289. PubMed ID: 32183656
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Lifestyle Modification for Secondary Stroke Prevention.
    Bailey RR
    Am J Lifestyle Med; 2018; 12(2):140-147. PubMed ID: 30202386
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Number needed to treat and baseline risks.
    McCormack JP
    CMAJ; 2008 Nov; 179(11):1174. PubMed ID: 19015570
    [No Abstract]   [Full Text] [Related]  

  • 94. Multi-level community interventions for primary stroke prevention: A conceptual approach by the World Stroke Organization.
    Brainin M; Feigin V; Bath PM; Collantes E; Martins S; Pandian J; Sacco R; Teuschl Y
    Int J Stroke; 2019 Oct; 14(8):818-825. PubMed ID: 31500553
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A new paradigm for primary prevention strategy in people with elevated risk of stroke.
    Feigin VL; Norrving B
    Int J Stroke; 2014 Jul; 9(5):624-6. PubMed ID: 24909195
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Influence of age and health behaviors on stroke risk: lessons from longitudinal studies.
    Kelly-Hayes M
    J Am Geriatr Soc; 2010 Oct; 58 Suppl 2(Suppl 2):S325-8. PubMed ID: 21029062
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Should risky treatments be reserved for secondary prevention? Theoretical considerations regarding risk-benefit tradeoffs.
    Westover MB; Eiseman NA; Bianchi MT
    J Clin Epidemiol; 2012 Aug; 65(8):877-86. PubMed ID: 22640567
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Open Questions in Acute Stroke Management and Stroke Prevention.
    Hennerici MG
    Cerebrovasc Dis; 2019; 47(5-6):205-206. PubMed ID: 31505503
    [No Abstract]   [Full Text] [Related]  

  • 99. National Initiatives to Prevent Myocardial Infarction and Stroke.
    Frieden TR; Foti KE
    JAMA; 2021 Apr; 325(14):1391-1392. PubMed ID: 33710271
    [No Abstract]   [Full Text] [Related]  

  • 100. Supervised and Individualized Lifestyle Medicine Therapy of a Patient after Myocardial Infarction-Case Study.
    Dvorák M; Sztancsik I; Babai L; Tóth M; Ács P
    J Cardiovasc Dev Dis; 2022 Jun; 9(6):. PubMed ID: 35735806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.